Brief: Zeria Pharmaceutical ends license agreement with EA Pharma

Zeria Pharmaceutical

16/06/2017 08:28

June 16 (Reuters) - Zeria Pharmaceutical Co Ltd  4559.T   
     
     
    * Says it ends a license agreement with EA Pharma Co Ltd,  
regarding proton pump inhibitor E3710  
    * Says it returns the exclusive development rights, joint 
sales rights and non-exclusive manufacture rights of inhibitor 
E3710  
     
    Source text in Japanese:https://goo.gl/VvTAUN 
    Further company coverage: 4559.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +8601082555111; 
Reuters Messaging: Pingping.Li@thomsonreuters.com@reuters.net))